Terms: = Sarcomas AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Treatment
28 results:
1. [Clinical characteristics of 272 437 patients with different histopathological subtypes of primary esophageal malignant tumors].
Wang LD; Li X; Song XK; Zhao FY; Zhou RH; Xu ZC; Liu AL; Li JL; Li XZ; Wang LG; Zhang FH; Zhu XM; Li WX; Zhao GZ; Guo WW; Gao XM; Li LX; Wan JW; Ku QX; Xu FG; Zhu AF; Ji HX; Li YL; Ren SL; Zhou PN; Chen QD; Bao SG; Gao HJ; Yang JC; Wei WM; Mao ZZ; Han ZW; Chang YF; Zhou XN; Han WL; Han LL; Lei ZM; Fan R; Wang YZ; Yang JJ; Ji Y; Chen ZJ; Li YF; Hu L; Sun YJ; Chen GL; Bai D; You D
Zhonghua Nei Ke Za Zhi; 2022 Sep; 61(9):1023-1030. PubMed ID: 36008295
[No Abstract] [Full Text] [Related]
2. Melatonin Increases the Sensitivity of Osteosarcoma Cells to Chemotherapy Drug Cisplatin.
Hosseini F; Shanehbandi D; Soleimanpour J; Yousefi B; Alemi F
Drug Res (Stuttg); 2022 Jul; 72(6):312-318. PubMed ID: 35636434
[TBL] [Abstract] [Full Text] [Related]
3. Synovial Sarcoma: A Series of Small Tumors in Active Duty Service Members.
Bates T; Kao E; Alderete J; Lybeck D
Mil Med; 2020 Sep; 185(9-10):e1864-e1868. PubMed ID: 32196117
[TBL] [Abstract] [Full Text] [Related]
4. 4-aryl/heteroaryl-4H-fused Pyrans as Anti-proliferative Agents: Design, Synthesis and Biological Evaluation.
Kumar D; Singh G; Sharma P; Qayum A; Mahajan G; Mintoo MJ; Singh SK; Mondhe DM; Bedi PMS; Jain SK; Gupta GK
Anticancer Agents Med Chem; 2018; 18(1):57-73. PubMed ID: 28925877
[TBL] [Abstract] [Full Text] [Related]
5. A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain.
Knoll J; Baghy K; Eckhardt S; Ferdinandy P; Garami M; Harsing LG; Hauser P; Mervai Z; Pocza T; Schaff Z; Schuler D; Miklya I
Life Sci; 2017 Aug; 182():57-64. PubMed ID: 28623006
[TBL] [Abstract] [Full Text] [Related]
6. miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.
Tseng JH; Bisogna M; Hoang LN; Olvera N; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Levine DA; Jelinic P
Sci Rep; 2017 Jun; 7(1):3614. PubMed ID: 28620240
[TBL] [Abstract] [Full Text] [Related]
7. High-dose-rate brachytherapy of rhabdomyosarcoma limited to the external auditory canal.
King MT; Voros L; Cohen GN; Lanning RM; Ganly I; O'Suoji CC; Wolden SL
Brachytherapy; 2017; 16(1):181-185. PubMed ID: 27528589
[TBL] [Abstract] [Full Text] [Related]
8. CT and MRI findings of radiation-induced external auditory canal carcinoma in patients with nasopharyngeal carcinoma after radiotherapy.
Zhang X; Bai S; Li H; Hu H; Duan X; Chen M; Wang D; Chen Y; Zhang F; Shen J
Br J Radiol; 2015 Jun; 88(1050):20140791. PubMed ID: 25827205
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of antitumor efficacy and toxicity of novel 6-nitro-2-(3-chloropropyl)-1H-benz[de]isoquinoline-1,3-dione in vivo in mouse.
Mukherjee A; Dutta S; Sanyal U
J Cancer Res Ther; 2013; 9(3):442-6. PubMed ID: 24125980
[TBL] [Abstract] [Full Text] [Related]
10. Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner via an immuno-modulatory circuit.
Saha S; Hossain DM; Mukherjee S; Mohanty S; Mazumdar M; Mukherjee S; Ghosh UK; Nayek C; Raveendar C; Khurana A; Chakrabarty R; Sa G; Das T
BMC Complement Altern Med; 2013 Sep; 13():230. PubMed ID: 24053127
[TBL] [Abstract] [Full Text] [Related]
11. NF-κB down-regulation and PARP cleavage by novel 3-α-butyryloxy-β-boswellic acid results in cancer cell specific apoptosis and in vivo tumor regression.
Qurishi Y; Hamid A; Sharma PR; Wani ZA; Mondhe DM; Singh SK; Zargar MA; Andotra SS; Shah BA; Taneja SC; Saxena AK
Anticancer Agents Med Chem; 2013 Jun; 13(5):777-90. PubMed ID: 23157593
[TBL] [Abstract] [Full Text] [Related]
12. The misdiagnosis of external auditory canal carcinoma.
Zhang T; Dai C; Wang Z
Eur Arch Otorhinolaryngol; 2013 May; 270(5):1607-13. PubMed ID: 22926989
[TBL] [Abstract] [Full Text] [Related]
13. Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-κB pathway independent of TRAF6, TAK1 and LUBAC.
Matta H; Gopalakrishnan R; Graham C; Tolani B; Khanna A; Yi H; Suo Y; Chaudhary PM
PLoS One; 2012; 7(5):e36601. PubMed ID: 22590573
[TBL] [Abstract] [Full Text] [Related]
14. A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study.
Gu R; Jia W; Zeng Y; Rao N; Hu Y; Li S; Wu J; Jin L; Chen L; Long M; Chen K; Chen L; Xiao Q; Wu M; Song E; Su F
BMC Cancer; 2012 May; 12():161. PubMed ID: 22548922
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of fluoren-NU as a novel antitumor agent.
Mukherjee A; Dutta S; Chashoo G; Bhagat M; Saxena AK; Sanyal U
Oncol Res; 2009; 17(9):387-96. PubMed ID: 19718945
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of dimethoxydop-NU as a novel anti-tumor agent.
Mukherjee A; Dutta S; Sanyal U
J Exp Clin Cancer Res; 2007 Dec; 26(4):489-97. PubMed ID: 18365543
[TBL] [Abstract] [Full Text] [Related]
17. [Replacement of invert-type artificial total scapula and shoulder joint prosthesis for malignant tumor].
Yin Q; Jiang Y; Xiao L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Mar; 21(3):240-3. PubMed ID: 17419200
[TBL] [Abstract] [Full Text] [Related]
18. Venom of Indian monocellate cobra and Russell's viper show anticancer activity in experimental models.
Debnath A; Chatterjee U; Das M; Vedasiromoni JR; Gomes A
J Ethnopharmacol; 2007 May; 111(3):681-4. PubMed ID: 17258413
[TBL] [Abstract] [Full Text] [Related]
19. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
Mookerjee A; Mookerjee Basu J; Dutta P; Majumder S; Bhattacharyya S; Biswas J; Pal S; Mukherjee P; Raha S; Baral RN; Das T; Efferth T; Sa G; Roy S; Choudhuri SK
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4339-49. PubMed ID: 16857809
[TBL] [Abstract] [Full Text] [Related]
20. Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent.
Samanta S; Pain A; Dutta S; Saxena AK; Shanmugavel M; Pandita RM; Qazi GN; Sanyal U
J Exp Ther Oncol; 2005; 5(1):15-22. PubMed ID: 16416597
[TBL] [Abstract] [Full Text] [Related]
[Next]
